Our UAE team contribute to the 8th edition of the Life Sciences Law Review

Published

May 05 2020

Written By

I am the head of the Intellectual Property Group for the Middle East offices and a partner in the International Commercial Group. I've practised in the UAE since 2006 and I'm ranked in IP Stars, Chambers & Partners, Legal 500 and Who's Who Legal for my commercial and intellectual property experience.

Surabhi Singhi

Partner
United Arab Emirates

I'm a partner in our Corporate Group, based in the UAE, where I work as a lead counsel in M&A transactions. I also specialise in provision of employment law solutions to our clients.

The eighth edition of The Life Sciences Law Review covers a total of 33 jurisdictions, providing an overview of legal requirements of interest to pharmaceutical, biotechnology and medical device companies. The chapters are arranged so as to describe requirements throughout the life cycle of a regulated product, from discovery to clinical trials, the marketing authorisation process and post-approval controls.

Partner, Melissa Murray and Senior Associate, Surabhi Singhi provided content for the regulatory framework in the life sciences sector in the United Arab Emirates.

Click here for the review >

This article was first published by Law Business Research Ltd in April 2020.